Economic burden of cancer does not stop after treatment
the ONA take:
According to a new study released online and being presented at the upcoming ASCO Annual Meeting in Chicago, IL, researchers have found that the economic burden of cancer extends into survivorship.
Specifically, cancer survivors deal with excess medical expenses, employment disability, and reduced production at work.
For the study, researchers analyzed the economic burden among elderly and nonelderly survivors with breast, colorectal, and prostate cancer in the United States using data from the Medical Expenditure Panel Survey between 2008 and 2012.
Researchers identified 1,568 female breast cancer survivors, 540 colorectal cancer survivors, and 1,170 prostate cancer survivors and compared their expenditures, productivity loss at work, and productivity loss at home to 100,000 people without a cancer history.
Results showed that elderly and nonelderly patients had between $9,278 and $20,238 of total annual economic burden depending on cancer type.
Nonelderly survivors of breast and colorectal cancer lost 3 and 7 days worth of productivity at work, respectively, and 3 and 5 days worth of productivity at home, respectively.
The economic burden of cancer extends into survivorship
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer
- Social Functioning Scores for Young Cancer Survivors Remain Lower Than Their Peers
- Mortality Rates Highest Among Youngest Oncology Patients, Particularly Minorities
- Survey Reveals Research Priorities for Cancer Patients, Oncology Nurses
- Smoking Increases Long-Term Risks From Radiotherapy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|